Literature DB >> 35747453

The effect of a standardised protocol for CIED insertion on complications and infection rates in a DGH.

Eliza Foster1, Guy Furniss2, Mark Dayer2.   

Abstract

Cardiac implantable electronic device (CIED)-related complications and infections typically lead to prolonged hospital stays and, very occasionally, death. A new CIED insertion protocol was implemented in a district general hospital. The primary objective of this study was to determine whether a significant reduction in complication and infection rates occurred after implementation of the new protocol. Medical records were reviewed for patients who had a CIED inserted in the two years pre- and post-protocol implementation, and any complications were identified in a one-year follow-up period. An increase in the complexity of the devices implanted after introduction of the protocol was observed. The number of complications was significantly reduced from 6.86% to 3.95% (p<0.0001). In the two years prior to protocol implementation, 14 of 871 (1.6%) patients suffered a CIED-related infection. In contrast, four of 683 (0.44%) patients suffered a CIEDrelated infection in the two years postimplementation. This was not statistically significant (p=0.093). In conclusion, implementing a standardised protocol for CIED insertion significantly reduced the rate of complications, and also reduced the rate of infection, but this was not statistically significant.
Copyright © 2021 Medinews (Cardiology) Limited.

Entities:  

Keywords:  cardiac implantable electronic device (CIED); device infection; pacemaker complications; pacemaker-related infection

Year:  2021        PMID: 35747453      PMCID: PMC8822513          DOI: 10.5837/bjc.2021.027

Source DB:  PubMed          Journal:  Br J Cardiol        ISSN: 0969-6113


  16 in total

1.  A surgical safety checklist to reduce morbidity and mortality in a global population.

Authors:  Alex B Haynes; Thomas G Weiser; William R Berry; Stuart R Lipsitz; Abdel-Hadi S Breizat; E Patchen Dellinger; Teodoro Herbosa; Sudhir Joseph; Pascience L Kibatala; Marie Carmela M Lapitan; Alan F Merry; Krishna Moorthy; Richard K Reznick; Bryce Taylor; Atul A Gawande
Journal:  N Engl J Med       Date:  2009-01-14       Impact factor: 91.245

2.  Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.

Authors:  Julio Cesar de Oliveira; Martino Martinelli; Silvana Angelina D'Orio Nishioka; Tânia Varejão; David Uipe; Anísio Alexandre Andrade Pedrosa; Roberto Costa; Andre D'Avila; Stephan B Danik
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-10

3.  Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis.

Authors:  A Da Costa; G Kirkorian; M Cucherat; F Delahaye; P Chevalier; A Cerisier; K Isaaz; P Touboul
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Cardiac Implantable Electronic Device Infection in Patients at Risk.

Authors:  Khaldoun G Tarakji; Christopher R Ellis; Pascal Defaye; Charles Kennergren
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

5.  A simple infection-control protocol to reduce serious cardiac device infections.

Authors:  Syed Y Ahsan; Bunny Saberwal; Pier D Lambiase; Chieh Y Koo; Simon Lee; Aerokondal B Gopalamurugan; Dominic P Rogers; Martin D Lowe; Anthony W C Chow
Journal:  Europace       Date:  2014-06-11       Impact factor: 5.214

6.  Mortality and cost associated with cardiovascular implantable electronic device infections.

Authors:  Muhammad R Sohail; Charles A Henrikson; Mary Jo Braid-Forbes; Kevin F Forbes; Daniel J Lerner
Journal:  Arch Intern Med       Date:  2011-09-12

Review 7.  Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE).

Authors:  Jonathan A T Sandoe; Gavin Barlow; John B Chambers; Michael Gammage; Achyut Guleri; Philip Howard; Ewan Olson; John D Perry; Bernard D Prendergast; Michael J Spry; Richard P Steeds; Muzahir H Tayebjee; Richard Watkin
Journal:  J Antimicrob Chemother       Date:  2014-10-29       Impact factor: 5.790

8.  Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis.

Authors:  Rabih O Darouiche; Matthew J Wall; Kamal M F Itani; Mary F Otterson; Alexandra L Webb; Matthew M Carrick; Harold J Miller; Samir S Awad; Cynthia T Crosby; Michael C Mosier; Atef Alsharif; David H Berger
Journal:  N Engl J Med       Date:  2010-01-07       Impact factor: 91.245

9.  Prevention of infections associated with permanent cardiac antiarrhythmic devices by implementation of a comprehensive infection control program.

Authors:  Abraham Borer; Jacob Gilad; Eytan Hyam; Francisc Schlaeffer; Pnina Schlaeffer; Seada Eskira; Phany Aloni; Abraham Wagshal; Amos Katz
Journal:  Infect Control Hosp Epidemiol       Date:  2004-06       Impact factor: 3.254

10.  Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.

Authors:  Mingyan Dai; Cheng Cai; Vaidya Vaibhav; M Rizwan Sohail; David L Hayes; David O Hodge; Ying Tian; Roshini Asirvatham; Jordan J Cochuyt; Congxin Huang; Paul A Friedman; Yong-Mei Cha
Journal:  JACC Clin Electrophysiol       Date:  2019-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.